Meghan Caruso, DO
Procedural Dermatology · Marlton, NJNPI 1821093436
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $94 of the $108 with a category attached, or 87.0%. 4 manufacturers reported payments, led by Lilly USA, LLC at 58.7% of the total. Reporting peaked in 2019 at $87 and has fallen 91.7% since, to $7 in 2025. That places this record below the midpoint for procedural dermatology clinicians in NJ, where the typical reported total is $1,506.
Across 10 payments — averaging $10.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$63
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$23
- Dermavant Sciences, Inc.$14
- Organon$7
What the payments were for
- Food & beverage$9487%
- Education$1413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 5 | $63 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $23 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Organon | 2 | $7 |
How this compares
$108 in reported general payments places this provider in the 20th percentile of 22 procedural dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $79,968 |
| Metronidazole | 32 | $3,613 |
| Ketoconazole | 142 | $3,309 |
| Clobetasol Propionate | 37 | $2,381 |
| Tretinoin | 27 | $1,636 |
| Betamethasone Dipropionate | 41 | $1,436 |
| Clindamycin Phosphate | 26 | $1,389 |
| ValacyclovirValacyclovir Hcl | 41 | $1,283 |
| Fluorouracil | 11 | $1,261 |
| Doxycycline Monohydrate | 25 | $1,157 |
| Mometasone Furoate | 42 | $1,026 |
| Triamcinolone Acetonide | 103 | $938 |
| Mupirocin | 52 | $860 |
| Minoxidil | 72 | $768 |
| Ammonium Lactate | 45 | $618 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Marlton
- Ashley Decker JensenMarlton$1K
- Naomi LawrenceMarlton$50
- Gwen AbelesMontvale$9K
- Kenneth GrossmanLittle Silver$9K
- Margarita LolisHackensack$9K
- Cheryl CitronLivingston$5K
- Dawn GangiMendham$5K
- David KikenFlorham Park$5K
- Marc HandlerHamilton$4K
- Jeffrey RapaportEnglewood Cliffs$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.